LSD18_STRLS
ID LSD18_STRLS Reviewed; 472 AA.
AC B5M9L6;
DT 16-MAY-2012, integrated into UniProtKB/Swiss-Prot.
DT 14-OCT-2008, sequence version 1.
DT 25-MAY-2022, entry version 30.
DE RecName: Full=Putative epoxidase LasC;
DE EC=1.14.13.-;
DE AltName: Full=Lasalocid biosynthesis protein Lsd18;
GN Name=lsd18; Synonyms=lasC;
OS Streptomyces lasalocidi (Streptomyces lasaliensis).
OG Plasmid pKSL.
OC Bacteria; Actinobacteria; Streptomycetales; Streptomycetaceae;
OC Streptomyces.
OX NCBI_TaxID=324833;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION IN LASALOCID BIOSYNTHESIS, AND
RP DISRUPTION PHENOTYPE.
RC STRAIN=ATCC 35851 / NRRL 3382R;
RX PubMed=19025863; DOI=10.1002/cbic.200800585;
RA Smith L., Hong H., Spencer J.B., Leadlay P.F.;
RT "Analysis of specific mutants in the lasalocid gene cluster: evidence for
RT enzymatic catalysis of a disfavoured polyether ring closure.";
RL ChemBioChem 9:2967-2975(2008).
RN [2]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC STRAIN=ATCC 35851 / NRRL 3382R; PLASMID=pKSL;
RX PubMed=19129623; DOI=10.1271/bbb.80631;
RA Migita A., Watanabe M., Hirose Y., Watanabe K., Tokiwano T., Kinashi H.,
RA Oikawa H.;
RT "Identification of a gene cluster of polyether antibiotic lasalocid from
RT Streptomyces lasaliensis.";
RL Biosci. Biotechnol. Biochem. 73:169-176(2009).
CC -!- FUNCTION: May catalyze the stereoselective double epoxidation reaction
CC leading to bisepoxyprelasalocid A, a bisepoxide intermediate in the
CC biosynthesis of the polyether antibiotic lasalocid A.
CC {ECO:0000269|PubMed:19025863}.
CC -!- COFACTOR:
CC Name=FAD; Xref=ChEBI:CHEBI:57692; Evidence={ECO:0000250};
CC -!- DISRUPTION PHENOTYPE: Deletion of this gene abolishes production both
CC of lasalocid and of the minor cometabolite iso-lasalocid without
CC leading to accumulation of an identifiable intermediate.
CC {ECO:0000269|PubMed:19025863}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; FM173265; CAQ64694.1; -; Genomic_DNA.
DR EMBL; AB449340; BAG85033.1; -; Genomic_DNA.
DR AlphaFoldDB; B5M9L6; -.
DR PRIDE; B5M9L6; -.
DR GO; GO:0071949; F:FAD binding; IEA:InterPro.
DR GO; GO:0004497; F:monooxygenase activity; IEA:UniProtKB-KW.
DR GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
DR Gene3D; 3.50.50.60; -; 1.
DR InterPro; IPR002938; FAD-bd.
DR InterPro; IPR036188; FAD/NAD-bd_sf.
DR Pfam; PF01494; FAD_binding_3; 1.
DR SUPFAM; SSF51905; SSF51905; 1.
PE 1: Evidence at protein level;
KW Antibiotic biosynthesis; FAD; Flavoprotein; Monooxygenase; Oxidoreductase;
KW Plasmid.
FT CHAIN 1..472
FT /note="Putative epoxidase LasC"
FT /id="PRO_0000417071"
SQ SEQUENCE 472 AA; 50490 MW; 695E8D1036E5C296 CRC64;
MTNTRSAVVL GGGMAGMLVS SMLARHVGSV TVIDRDAFPA GPDLRKGVPQ ARHAHILWSG
GARIVEELLP GTTDRLLGAG AHRIGIPDGQ VSYTAYGWQH RFPEAQFMIA CSRALLDWTV
REETLREERI ALVEKTEVLA LLGDAGRVTG VRVRDQESGE EREVPADLVV DTTGRGSPSK
RLLAELGLPA PEEEFVDSGM VYATRLFRAP EAAATNFPLV SVHADHRAGR PGCNAVLMPI
EDGRWIVTVS GTRGGEPPAD DEGFARFARD GVRHPLVGEL IAKAQPLTSV ERSRSTVNRR
LHYDRLATWP EGLVVLGDAV AAFNPVYGHG MSAAAHSVLA LRSQLGQRAF QPGLARAAQR
AIAVAVDDAW VLATSHDIGY PGCRTQTRDP RLTRHAGERQ RVTDLVGLTA TRNQVVNRAA
VALNTLSAGM ASMQDPAVMA AVRRGPEVPA PTEPPLRPDE VARLVSGAGV TA